News

SOLID DOUBLE-DIGIT REVENUE GROWTH IN 2025 DRIVEN BY STRONG CONTRIBUTION FROM INTERNATIONAL MARKETS AND NEW BUSINESS UNITS

PUBLICATION OF THE 2026 CORPORATE EVENTS CALENDAR

Pharmanutra accelerates international expansion in the Far East through the Alibaba ecosystem

Cetilar® Nutrition confirmed as Official Nutrition Partner of the 2026 Giro d’Italia

PHARMANUTRA S.P.A. LISTED AMONG THE WORLD’S BEST COMPANIES FOR SUSTAINABLE GROWTH BY “TIME” MAGAZINE

BOARD OF DIRECTORS APPROVES THE INTERIM MANANGEMENT REPORT AS OF SEPTEMBER 30, 2025

MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUERS SECURITIES

Pharmanutra awards ten graduation prizes to young graduates of the University of Parma

SIDERAL® FORTE AWARDED BEST NUTRACEUTICAL PRODUCT AT SPAZIO NUTRIZIONE

INITIATION OF SHARE BUY-BACK PROGRAM

BOARD OF DIRECTORS APPROVES THE HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2025

Pharmanutra at GOAL! Festival 2025: ethics, health and sports culture

GREAT MARKET RESPONSE FOR SIDEVIT® B12 JUST SIX MONTHS AFTER ITS LAUNCH IN ITALY

Pharmanutra renews sponsorship with Pisa Sporting Club

PharmaNutra launches its official store on Amazon

PHARMANUTRA LAUNCHES THE NEW NUTRITIONAL SUPPLEMENT APPORTAL® BOOST

THE BOARD OF DIRECTORS APPROVES THE INTERIM MANAGEMENT REPORT AS AT MARCH 31, 2025

Allegato 3F – Aprile 2025

PHARMANUTRA S.P.A.: PARTNERSHIP WITH GIRO D’ITALIA

SHAREHOLDERS’ MEETING OF 16/04/2025 – REPORT OF VOTING RESULTS